Draft Guidance for Industry: Quality Guidance: Applications for Drug Identification Numbers (DINAs) for Pharmaceuticals

This document is intended to provide guidance with respect to the Quality (Chemistry and Manufacturing) portion of Applications for Drug Identification Numbers (DINAs) for chemical entities. The purpose of the guidance document is to outline the Quality technical requirements and to assist sponsors in preparing the DINAs to ensure an effective and efficient review process.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-09-03

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data